Biolife Solutions Stock Market Value
| BLFS Stock | USD 24.87 1.11 4.27% |
| Symbol | BioLife |
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of BioLife Solutions. If investors know BioLife will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about BioLife Solutions listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 6.4 | Earnings Share (0.38) | Revenue Per Share | Quarterly Revenue Growth 0.312 | Return On Assets |
The market value of BioLife Solutions is measured differently than its book value, which is the value of BioLife that is recorded on the company's balance sheet. Investors also form their own opinion of BioLife Solutions' value that differs from its market value or its book value, called intrinsic value, which is BioLife Solutions' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because BioLife Solutions' market value can be influenced by many factors that don't directly affect BioLife Solutions' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between BioLife Solutions' value and its price as these two are different measures arrived at by different means. Investors typically determine if BioLife Solutions is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, BioLife Solutions' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
BioLife Solutions 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to BioLife Solutions' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of BioLife Solutions.
| 10/26/2025 |
| 01/24/2026 |
If you would invest 0.00 in BioLife Solutions on October 26, 2025 and sell it all today you would earn a total of 0.00 from holding BioLife Solutions or generate 0.0% return on investment in BioLife Solutions over 90 days. BioLife Solutions is related to or competes with Kestra Medical, Novocure, Azenta, STAAR Surgical, Phreesia, Pulse Biosciences, and Neogen. BioLife Solutions, Inc. develops, manufactures, and supplies bioproduction tools and services for the cell and gene ther... More
BioLife Solutions Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure BioLife Solutions' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess BioLife Solutions upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.09) | |||
| Maximum Drawdown | 13.74 | |||
| Value At Risk | (4.03) | |||
| Potential Upside | 4.07 |
BioLife Solutions Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for BioLife Solutions' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as BioLife Solutions' standard deviation. In reality, there are many statistical measures that can use BioLife Solutions historical prices to predict the future BioLife Solutions' volatility.| Risk Adjusted Performance | (0.04) | |||
| Jensen Alpha | (0.25) | |||
| Total Risk Alpha | (0.38) | |||
| Treynor Ratio | (0.10) |
BioLife Solutions January 24, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.04) | |||
| Market Risk Adjusted Performance | (0.09) | |||
| Mean Deviation | 1.71 | |||
| Coefficient Of Variation | (1,674) | |||
| Standard Deviation | 2.41 | |||
| Variance | 5.79 | |||
| Information Ratio | (0.09) | |||
| Jensen Alpha | (0.25) | |||
| Total Risk Alpha | (0.38) | |||
| Treynor Ratio | (0.10) | |||
| Maximum Drawdown | 13.74 | |||
| Value At Risk | (4.03) | |||
| Potential Upside | 4.07 | |||
| Skewness | 1.16 | |||
| Kurtosis | 3.46 |
BioLife Solutions Backtested Returns
BioLife Solutions secures Sharpe Ratio (or Efficiency) of -0.0694, which signifies that the company had a -0.0694 % return per unit of risk over the last 3 months. BioLife Solutions exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm BioLife Solutions' Standard Deviation of 2.41, risk adjusted performance of (0.04), and Mean Deviation of 1.71 to double-check the risk estimate we provide. The firm shows a Beta (market volatility) of 1.47, which signifies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, BioLife Solutions will likely underperform. At this point, BioLife Solutions has a negative expected return of -0.17%. Please make sure to confirm BioLife Solutions' information ratio, potential upside, as well as the relationship between the Potential Upside and rate of daily change , to decide if BioLife Solutions performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.12 |
Insignificant reverse predictability
BioLife Solutions has insignificant reverse predictability. Overlapping area represents the amount of predictability between BioLife Solutions time series from 26th of October 2025 to 10th of December 2025 and 10th of December 2025 to 24th of January 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of BioLife Solutions price movement. The serial correlation of -0.12 indicates that less than 12.0% of current BioLife Solutions price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.12 | |
| Spearman Rank Test | -0.18 | |
| Residual Average | 0.0 | |
| Price Variance | 0.33 |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for BioLife Stock Analysis
When running BioLife Solutions' price analysis, check to measure BioLife Solutions' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioLife Solutions is operating at the current time. Most of BioLife Solutions' value examination focuses on studying past and present price action to predict the probability of BioLife Solutions' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioLife Solutions' price. Additionally, you may evaluate how the addition of BioLife Solutions to your portfolios can decrease your overall portfolio volatility.